Clinical Trials

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms

NCT07467330 2026-03-12

Dalpiciclib Combined With Endocrine Therapy and Metronomic Capecitabine vs Dalpiciclib Combined With Endocrine Therapy for First-line Treatment

Phase 3 Recruiting

258 enrolled

Breast Neoplasms

NCT07464769 2026-03-11

KompXX

358 enrolled

BreastGastrointestinal

Breast Neoplasms, Colorectal Neoplasms

NCT03877029 2026-03-09

Long-term Effects of Breast Cancer Treatment

Completed

4,487 enrolled

Breast Neoplasms

NCT06704659 2026-03-09

RAY-no-BAN

60 enrolled

Breast Neoplasms, Recurrence

NCT07425379 2026-02-24

Prehabilitation in Breast Cancer Surgery

54 enrolled

Breast Neoplasms

NCT06104371 2026-02-23

SentiNeo2

459 enrolled

Breast Neoplasms

NCT07416253 2026-02-18

Trastuzumab Rezetecan vs Trastuzumab Deruxtecan in the Neoadjuvant Treatment of HER2 Positive Breast Cancer

68 enrolled

Breast Neoplasms

NCT07371702 2026-01-29

PERMS

Not yet recruiting

3,000 enrolled

Breast Neoplasms

NCT07338721 2026-01-15

Does Ultrasound Guidance Axillary Incision Improve Sentinel Lymph Node Detection in Breast Cancer?

40 enrolled

Breast Neoplasms

NCT06032390 2026-01-14

AIMS Norway

150,000 enrolled

Breast Neoplasms

NCT06967103 2026-01-08

QL1706 for the Neoadjuvant Treatment of HR+/HER2- Breast Cancer

Phase 2 Recruiting

238 enrolled

Breast Neoplasms

NCT07327021 2026-01-08

NOGA

Phase 2 Recruiting

54 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02698202 2025-12-19

Screening for Breast Cancer With Digital Breast Tomosynthesis

26,877 enrolled

Breast Neoplasms

NCT07274800 2025-12-10

UHF vs HF-EBC

60 enrolled

Breast Neoplasms

NCT07273357 2025-12-09

FUTURE

Not yet recruiting

200 enrolled

Breast Neoplasms

NCT07252843 2025-11-28

Integrating Clinical, Protein Expression, and Genetic Markers to Predict Lymphedema in Breast Cancer

Completed

133 enrolled

Breast Neoplasms, Lymphedema

NCT07240584 2025-11-21

Prehab of BC

30 enrolled

Breast Neoplasms, Fatigue, Lymphedema

NCT07243418 2025-11-21

Hetrombopag for the Prevention of ADC-Induced Thrombocytopenia in Breast Cancer: An Exploratory, Dual-Cohort, Phase 2 Study

72 enrolled

Phase NA Active not recruiting

Breast Neoplasms

NCT06522971 2025-09-10

CancerBeat

55 enrolled

Breast Neoplasms

NCT07146009 2025-08-28

Targeted Nerve Surgery for the Prevention of Post-Mastectomy Pain Syndrome: A Randomized Trial

60 enrolled

Breast Neoplasms

NCT03232541 2025-08-24

The Effects of Acupuncture and the Therapist´s Communication on Chemotherapy Induced Nausea and Vomiting

BreastGastrointestinalGenitourinary

198 enrolled

Urinary Bladder Neoplasms, Breast Neoplasms, Vomiting, Colorectal Neoplasms

NCT05735795 2025-08-24

Feasibility of Carbon-Dye Marking of Axillary Lymph Nodes Before Neoadjuvant Chemotherapy in Patients With Breast Cancer

50 enrolled

Breast Neoplasms, Lymphatic Metastasis

NCT07136974 2025-08-22

Efficacy of TQB2102 Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer.

280 enrolled

Breast Neoplasms

NCT07101159 2025-08-03

Dalpiciclib as Adjuvant Therapy for HR-positive/HER2-negative Early-stage Patients

200 enrolled

Breast Neoplasms

NCT03755141 2025-07-22

Efficacy and Safety of Trastuzumab Biosimilar (Herzuma®) Plus Treatment of Physician's Choice (TPC) in Patients With HER-2 Positive Metastatic Breast Cancer

Phase 2 Completed

109 enrolled 7 charts

Breast Neoplasms

NCT06351865 2025-07-17

PRC

50 enrolled

Breast Neoplasms

NCT07059104 2025-07-16

Implant-based Breast Reconstruction in Post-bariatric Women - a Registry-based National Study

20,000 enrolled

Breast Neoplasms, Weight Loss

NCT06243796 2025-07-11

Seroma Formation After Modified Radical Mastectomy With Flap Fixation Technique in Breast Cancer Patients

70 enrolled 8 charts

Breast Neoplasms

NCT04526561 2025-07-09

Reconstructions With Back Donor Site Flaps and Validation of Quality of Life Scales

550 enrolled

Breast Neoplasms

NCT05722795 2025-07-09

I-CONIC

40 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT03578484 2025-07-04

Breast Aesthetics by Three Dimensional Measures

Active not recruiting

32 enrolled

Breast Neoplasms

NCT04714463 2025-07-03

Effects of Expectations and Body Image in Breast Reconstruction

500 enrolled

Breast Neoplasms

NCT05222100 2025-07-03

Effect of Breast Implants om Mammography Screening

2,500 enrolled

Breast Neoplasms

NCT05233891 2025-07-03

ValPlast

500 enrolled

Gigantomastia, Breast Neoplasms

NCT05363189 2025-07-03

BestDIEP

380 enrolled

Breast Neoplasms

NCT06195865 2025-07-03

GoBreast II

250 enrolled

Breast Neoplasms

NCT06751407 2025-07-03

Single-level and Two-level Serratus Posterior Superior Intercostal Plan Block (SPSIPB)

50 enrolled

Breast Neoplasms, Pain

NCT05663723 2025-06-26

Photobiomodulation for Prevention of Chemotherapy-induced Peripheral Neuropathy in Women With Breast Cancer

186 enrolled

Breast Neoplasms, Peripheral Nervous System Diseases

NCT02824484 2025-06-25

A Guided Written Disclosure Intervention to Promote Post-traumatic Growth in Cancer Patients GUIDED WRITTEN DISCLOSURE

250 enrolled

BreastGastrointestinal

Breast Neoplasms, Neoplasms, Colorectal Neoplasms

NCT03941223 2025-06-25

Regional Anesthesia for Breast Surgery

Phase NA Withdrawn

Breast Neoplasms

NCT03992859 2025-06-25

Continuous Serrates Plane Block in Axillary Dissection

15 enrolled

Phase NA Active not recruiting

Breast Neoplasms

NCT04461808 2025-06-25

MAITA

10,156 enrolled

Phase NA Active not recruiting

Breast Neoplasms

NCT04862429 2025-06-25

BoCCE

200 enrolled

Breast Neoplasms, Calcinosis

NCT07037537 2025-06-25

Evaluation of the Effectiveness and Safety of Laparoscopic Assisted Mastectomy With Preservation of Nipple and Areola, Immediate One-step Breast Reconstruction With Pectoral Muscle Prosthesis and Patch, and Simultaneous Autologous Fat Transplantation

26 enrolled

Breast Neoplasms

NCT07037576 2025-06-25

Efficacy and Safety of Prepectoral Prosthesis Immediate One-Stage Breast Reconstruction Versus Two-Stage Expander/Prosthesis Reconstruction in Postoperative Adjuvant Radiotherapy Breast Cancer Patients: A Prospective, Single-Center, Cohort Study

104 enrolled

Breast Neoplasms

NCT06629896 2025-06-24

CEM

2,200 enrolled

Phase 2 Active not recruiting

Breast Neoplasms, Disease

NCT06394661 2025-06-23

Serplulimab Plus Chemotherapy for Early-stage HR+/HER2- Breast Cancer

109 enrolled

Breast Neoplasms

NCT06927180 2025-06-23

SHR-A1811 Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BC

Phase 2 Recruiting

180 enrolled

Pathologic Complete Response, Breast Neoplasms

NCT07023796 2025-06-17

Autologous Fat Infiltration Versus General Measures as Treatment in Radiodermatitis Induced for Radiotherapy in Breast Cancer Patients

22 enrolled